Coronavirus More Likely to Infect People with Blood Type A, Finds Study
By HospiMedica International staff writers Posted on 23 Mar 2020 |
Illustration
A new preliminary study in China has found that people having blood type A could be more vulnerable to the coronavirus, while those having type O blood might be more resistant. According to researchers from the Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University (Wuhan, China) who studied COVID-19 in its outbreak epicenter, Wuhan, and the city of Shenzhen, the proportion of Type-A patients both infected and killed by the coronavirus was found to be “significantly” higher than those with the same blood type among the general public. On the other hand, Type O patients comprised a smaller proportion of those who were infected as well as killed by the coronavirus.
In their study, the researchers compared the blood types of 2,173 confirmed coronavirus patients in Wuhan and Shenzhen with over 3,694 healthy residents in the Wuhan area. According to the published research, 31.16% of the residents in Wuhan had Type-A blood, as against 37.75% of the surveyed coronavirus patients at the Wuhan Jinyintan Hospital having the same blood type. Out of these surveyed coronavirus patients, 25.8% had Type-O blood, as compared to 33.84% of the general population, while 25.8% had Type-O blood, as against 33.84% of the general population. An examination of 206 patients who had died from the coronavirus revealed that 85 victims, or 41.26%, had Type-A blood, while only 52 victims, or about a quarter, had Type-O blood.
“People of blood group A might need particularly strengthened personal protection to reduce the chance of infection,” according to the researchers, who however termed the study as preliminary and stated that more work was needed to confirm the findings.
Related Links:
Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University
In their study, the researchers compared the blood types of 2,173 confirmed coronavirus patients in Wuhan and Shenzhen with over 3,694 healthy residents in the Wuhan area. According to the published research, 31.16% of the residents in Wuhan had Type-A blood, as against 37.75% of the surveyed coronavirus patients at the Wuhan Jinyintan Hospital having the same blood type. Out of these surveyed coronavirus patients, 25.8% had Type-O blood, as compared to 33.84% of the general population, while 25.8% had Type-O blood, as against 33.84% of the general population. An examination of 206 patients who had died from the coronavirus revealed that 85 victims, or 41.26%, had Type-A blood, while only 52 victims, or about a quarter, had Type-O blood.
“People of blood group A might need particularly strengthened personal protection to reduce the chance of infection,” according to the researchers, who however termed the study as preliminary and stated that more work was needed to confirm the findings.
Related Links:
Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans